Home » Posts tagged with » Stephen J. Farr
Zogenix bags Fintepla FDA approval for Dravet syndrome treatment

Zogenix bags Fintepla FDA approval for Dravet syndrome treatment

Fintepla FDA approval : Zogenix has bagged approval from the US Food and Drug Administration (FDA) for Fintepla (fenfluramine) oral solution, CIV for the treatment of seizures associated with Dravet syndrome in patients aged two years of age and older. Considered to be a life-threatening, rare and chronic type of epilepsy, Dravet syndrome is usually […]